NY-XANDR
14.5.2019 14:02:09 CEST | Business Wire | Press release
Xandr, AT&T’s advanced advertising and analytics company, has announced the formation of Community, a curated marketplace of publishers that enables advertisers to reach their audiences at scale in a brand-safe, privacy-protected, premium video environment. Community is built on Xandr’s powerful technology and consumer insights, enabling buyers and sellers to drive better business outcomes. This new marketplace is the first-step towards the future convergence of linear TV and digital.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190514005493/en/
Community simplifies and improves an advertiser’s ability to connect with hard-to-reach audiences, regardless of how they engage with content across traditional TV, connected TV, OTT, mobile, and online. Community also offers controls to programmers and publishers to achieve better yield on their premium multiplatform inventory.
“After only eight short months since the launch of Xandr, Community delivers on our promise of a brand-safe, insight-driven, premium video marketplace,” said Brian Lesser, CEO of Xandr. “Building on one of the largest technology platforms in the industry and integrating Xandr’s unique audience insights from AT&T, we created the foundation of Community. Now, with the incredible inventory from our inaugural Community partners, the marketplace is open.”
Community is a Multi-Screen Premium Video Marketplace
Increasingly, marketers are looking for simpler ways to connect with audiences across digital, video, and television.
Xandr is committed to providing advertisers access to scaled, brand-safe, premium content with unique insights across wireless, broadband, and video. By aggregating inventory across publishers and creating multi-seller deals, publishers can increase the value of their inventory and improve monetization, while advertisers have the benefit of better access to content and increased scale.
WarnerMedia (including Otter Media), Vice, Hearst Magazine, Newsy, Philo, Tubi, and Xumo join as inaugural Community partners, adding more than 15 premium content providers to the marketplace and reaching more than 50 million active monthly users on streaming services. In addition to WarnerMedia’s portfolio across CNN, TNT, TBS, truTV, B/R Live, Warner Bros., Crunchyroll, Rooster Teeth and VRV, Community will also encompass additional premium video content from other AT&T owned-and-operated properties including DIRECTV NOW and AT&T WatchTV.
“Community’s vision aligns perfectly with our long-term strategy of pairing our high-quality content with breakthrough insights to deliver better ad experiences and drive results for advertisers,” said Donna Speciale, president of WarnerMedia Ad Sales. “As a launch partner, we are excited to be able to offer clients extended digital audience opportunities through Community, and we look forward to working with Xandr on enhanced addressable solutions with our live national linear television inventory in the near future.”
Added Henry Embleton, head of ad products and strategy, Ellation (part of Otter Media), “We rely on our programmatic partners to deliver the best possible ad supported experience for our fans at Crunchyroll, Rooster Teeth, and VRV, however, that information is not always accurate or reliable. Xandr is going to be a programmatic game changer – delivering deep, rich, dependable data from AT&T to enhance our user experience, paired with an expansive reach to help us grow our bottom line.”
“We're pleased to be working through Community to pair the largest free ad-supported movie and TV audience with unique addressable targeting through AT&T data,” said Mark Rotblat, chief revenue officer, Tubi.
“At Philo, we want to offer the best experience for both our subscribers and advertisers. By partnering with Xandr, we build upon our seamless programmatic solutions that allow advertisers to reach their audiences via the Philo platform,” said Reed Barker, Philo’s head of advertising.
Community is Cross-Screen Addressable
Increasingly, marketers are looking for ways to buy media across multiple touchpoints to connect with hard-to-reach audiences as digital, video, and TV converge. To better power advertising experiences across screens for consumers, Xandr’s Cross-Screen Addressable solution is now integrated within Community, allowing advertisers to combine the power of addressable TV with the precision and scale of digital.
Xandr’s Cross-Screen Addressable solution enables advertisers to define their audience and identify the households that match their desired attributes. Then, through Community, advertisers can serve relevant messages to that same audience across screens to amplify the impact of their campaign.
Community is Accountable
Using Xandr’s data, based on AT&T’s first-party consumer insights, Community will improve the efficacy and efficiency of media buying.
Community is layered with Xandr Audience Segments that are built from AT&T’s 170 million direct-to-consumer relationships. Community’s privacy-forward approach to attribution will enable advertisers to reach their audiences based on intent, interest, and lifestyle attributes.
Similar to the insights advertisers can glean from a Cross-Screen Addressable campaign, Xandr’s unique consumer analytics will help marketers determine the effectiveness of their media buys, including the impact on brand health and the ability to aid in frequency capping of a given brand message. Using these powerful attribution tools, marketers will have the ability to gain greater insights and become more effective with each campaign they run within Community.
Community is Reaching Consumers Where They Are
Xandr recently released original, consumer-centric research, called the Relevance Report . The report surveyed more than 3,000 people to learn how they consume content and their advertising preferences.
Consumers are spending more time than ever engaging with content. The report revealed 68% of consumers spend the majority of their free time engaging with content, and 76% said content enriches and enhances their lives, with 72% stating their day wouldn’t be complete without it.
Despite this engagement with content, consumers, especially younger audiences, have become proficient at tuning out content and advertising that they do not perceive as immediately relevant to them. About 57% of respondents say they do not want to engage with ads because they are not relevant to them and, most importantly, 66% wish advertisements were more relevant to them and their lives.
Community is Making TV More Data-Driven
Xandr is the leader in advanced TV advertising*. Community builds on the expertise of more than 3,000 addressable and advanced TV campaigns, and will begin to incorporate robust TV management tools. Using its technology and data analytics, Community will create more relevant advertising opportunities and help optimize yield management of inventory for live, playback, and VOD on traditional linear TV.
Community is Privacy-Protected
Xandr is committed to protecting data and privacy, while providing valuable and relevant advertising to consumers. Responsible data usage has been part of AT&T’s DNA for more than 143 years, always giving customers the power of choice to opt in or out of relevant advertising.
About Xandr
Xandr is creating a better solution for advertisers and publishers to find and reach specific audiences at scale in trusted, premium content environments. As a current leader in advanced TV advertising with the one of the best technology platforms, AppNexus, we help advertisers deliver the right message, at the right time, on almost any device. We are rooted in a tradition of responsible data usage. For more than 143 years, AT&T has used data and technology to inform and improve the customer experience.
*Source: The Myers Report Survey on Media Company B2B Relationships, Services and Value, Q1 2019.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190514005493/en/
Contact:
Media Rob Wheeler, robert.wheeler@xandr.com , 212-837-8121 Kelly Liyakasa, kelly.liyakasa@xandr.com , 347-224-1096
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 11:18:00 CEST | Press release
Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0
FPT Launches Flezi Foundry™, Advancing AI-Augmented Delivery for Global Enterprises22.5.2026 10:11:00 CEST | Press release
Global IT corporation FPT announced the launch of Flezi Foundry™ (FPT Digital Foundry™), an AI-augmented delivery platform for software development and IT operations. Built around a governed Service-as-a-Software model, the platform combines autonomous AI agents, human expert oversight, secure infrastructure, and outcome-based delivery mechanisms to help enterprises modernize technology delivery as AI agents become part of software engineering and IT operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521235556/en/ Flezi Foundry applies Agentic Engineering, a structured delivery approach for software development and IT operations. The model brings AI agents into delivery workflows with human supervision, governance, transparency, and performance measurement built into the process. Flezi Foundry operates through two service modes: Agentic Development Lifecycle (ADLC) supports software development by using specialize
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
